Pure Global

A Multicenter Clinical Study of rTMS for Parkinson's Disease - Trial NCT06009471

Access comprehensive clinical trial information for NCT06009471 through Pure Global AI's free database. This phase not specified trial is sponsored by Affiliated Hospital of Nantong University and is currently Recruiting. The study focuses on Parkinson's Disease. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06009471
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06009471
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Multicenter Clinical Study of rTMS for Parkinson's Disease

Study Focus

Parkinson's Disease

Routine treatment in Neurology

Interventional

other

Sponsor & Location

Affiliated Hospital of Nantong University

Nantong, China

Timeline & Enrollment

N/A

Jul 01, 2023

Aug 01, 2025

200 participants

Primary Outcome

Unified Parkinson's disease rating Scale ๏ผˆUPDRS๏ผ‰,Montreal Cognitive Assessment Scale (MoCA),King's Parkinson's Pain Assessment (KPPS),PD Sleep Scale (PDSS),Activities of daily living Assessment - Barthel

Summary

Through rTMS, motor dysfunction and non-motor dysfunction of PD patients can be improved,
 working and living ability and quality of life of patients can be improved, and social burden
 and family burden can be reduced.

ICD-10 Classifications

Parkinson disease
Parkinsonism in diseases classified elsewhere
Dementia in Parkinson disease
Secondary parkinsonism
Postencephalitic parkinsonism

Data Source

ClinicalTrials.gov

NCT06009471

Non-Device Trial